top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

BIOTECH

Enhanced Genomics Secures $19M Series A Extension to Advance Therapeutics Pipeline

Biotech secures fresh investment to expand drug discovery in autoimmune and common diseases.

 Featured Articles. 

7-format11240.jpg
PHARMA

Closed Loop Medicine Brings Personalised GLP-1 Dosing to the U.S with WeDosify

7-format11240.jpg
BIOTECH

One Million New Species Discovered

7-format11240.jpg
SPONSORED

Accelerating cell therapy development and manufacturing

7-format11240.jpg
BIOTECH

International Team to Build First Fully Synthetic Chloroplast Genomes

7-format11240.jpg
BIOTECH

Using Jumping Genes for Safer, More Accurate DNA Editing

7-format11240.jpg
BIOPROCESSING

Fujifilm Rebrands Life Sciences Units to Strengthen Unified Market Presence Under ‘Partners for Life’ Strategy

7-format11240.jpg
PHARMA

Vedanta Biosciences Announces Phase 2 Results for VE202 in Ulcerative Colitis, Strengthens Focus on Lead Program VE303

7-format11240.jpg
BIOTECH

SolasCure Receives FDA Fast Track Designation for Aurase Wound Gel in Treatment of Calciphylaxis Ulcers

7-format11240.jpg
SPONSORED

Preparing your cell culture workflow to scale for success

 Latest News. 

19th September, 2025

01.

Closed Loop Medicine Brings Personalised GLP-1 Dosing to the U.S with WeDosify

UK start-up's new platform promises to cut GLP-1 discontinuation rates by tailoring dose escalation to each patient's response.

17th September, 2025

02.

FUJIFILM Biosciences Unveils HEK293 Perfusion Medium for Gene Therapy

First commercial cell culture solution tailored for HEK293 cells in perfusion, enabling high-density growth, scalable viral vector production, and consistent quality for advanced therapies.

16th September, 2025

03.

Enhanced Genomics Secures $19M Series A Extension to Advance Therapeutics Pipeline

Biotech secures fresh investment to expand drug discovery in autoimmune and common diseases.

8th September, 2025

04.

Digital Health Gains Still Out of Reach, BMJ Commission Finds

Despite heavy investment, a BMJ Future Health Commission survey finds digital health has yet to ease workloads or cut costs, with EHR usability, interoperability, and training gaps undermining clinician trust.

Read More

Editor's Selects.

Weighing the Cost of Semaglutide

Women's Health Therapeutics Market Enters Transformative Growth Phase

Essential Strategies for Scaling Up Biologics

Biotechnology in Agriculture - Feeding the World’s Growing Population

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page